Current price is less than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Jubilant Life Sciences divested its entire stake in Safe Foods Corporation, consisting of 5,40,463 shares

Jubilant Life Sciences divests 10% in Safe Foods Corp for Rs 134 cr

Jubilant Ingrevia rallied 3.47% to Rs 786.50 after its wholly owned subsidiary, Jubilant Life Sciences International, Singapore divested its entire 10% stake from Safe Foods Corporation for $18.2 million (approx. Rs 134.20 crore).

Jubilant Ingrevia spurts after its Singaporean arm offloads 10% stake of Safe Foods Corp.

Jubilant Ingrevia on Wednesday said its subsidiary Jubilant Life Sciences International Pte Ltd has divested its 10 per cent stake in Safe Foods Corporation for a consideration of $18.2 million

Jubilant Ingrevia arm divests 10% stake in Safe Foods Corp for $18.2 mn

Salisbury-based Jubilant Cadista Pharmaceuticals Inc is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of Noida-based Jubilant Life Sciences.

Drug makers Granules India, Jubilant Cadista recall products in US market

Jubilant Cadista is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of the Noida-based Jubilant Life Sciences Company.

Drug firms Granules India, Jubilant Cadista recall products in US market

Anurag Roy has over 21 years’ experience working in leading pharmaceuticals/chemicals Companies such as DSM, Dr. Reddy’s Labs, BASF and Jubilant Life Sciences.

Anurag Roy joins Astec Lifesciences board panel as CEO; Stock dives 4%

Anurag Roy joins Astec Lifesciences as CEO and Whole-time Director; Stock dives 4%

During the second wave of COVID-19, stocks of pharmaceutical, oxygen and other companies involved in tackling COVID-19 have been in focus. But today, there may be some pharmaceutical stocks that may draw more attention of investors.Given is the list of stocks:

Stocks to watch out: Cipla, Jubilant Life Sciences, Godrej Consumer Products, Siemens, Dr Reddy’s among others

Companies like Cipla, Mylan, Jubilant Life Sciences, Hetero Drugs, Syngene International and Dr Reddy’s Laboratories are also manufacturing Remdesivir for the Indian market.

As Covid cases rise, Zydus to scale up Remdesivir production

Jubilant Life Sciences consolidated net profit rises 52.39% in the December 2020 quarter

Jubilant Pharmova (erstwhile Jubilant Life Sciences) hit an upper circuit of 5% at Rs 954.45 after the company reported 52% jump in net profit to Rs 310 crore on a 15% rise in revenue from operations to Rs 2,664 crore in Q3 FY21 over Q3 FY20.

Jubilant Pharmova spurts after recording 52% YoY growth in Q3 PAT

Jubilant Pharmova Ltd, formerly Jubilant Life Sciences Ltd, is an India-based pharmaceuticals company. The Company's segments include Pharmaceuticals, Contract Research and Development Services, and Proprietary Novel Drugs. The Pharmaceuticals segment operates through Jubilant Pharma Limited, which is engaged in manufacturing and supply of Radiopharmaceuticals in the United States, Allergy Therapy Products, Contract Manufacturing of Sterile Injectables and Non-sterile products, Active Pharmaceutical Ingredients and Solid Dosage Formulations. The Contract Research and Development Services segment operates through Jubilant Biosys Limited, which provides research to global pharmaceutical innovators through two research centers in Bengaluru and Noida in India. Its Proprietary Novel Drugs business through Jubilant Therapeutics Inc., is a patient-centric biopharmaceutical, developing therapies in the area of oncology and auto-immune disorders.

Jubilant Pharmova Ltd

Jubilant Pharmova Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Jubilant Life Sciences divests 10% in Safe Foods Corp for Rs 134 cr

Jubilant Ingrevia spurts after its Singaporean arm offloads 10% stake of Safe Foods Corp.

Jubilant Ingrevia arm divests 10% stake in Safe Foods Corp for $18.2 mn

Drug makers Granules India, Jubilant Cadista recall products in US market

Drug firms Granules India, Jubilant Cadista recall products in US market

Anurag Roy joins Astec Lifesciences board panel as CEO; Stock dives 4%

Anurag Roy joins Astec Lifesciences as CEO and Whole-time Director; Stock dives 4%

Jubilant Pharmova Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Jubilant Life Sciences divests 10% in Safe Foods Corp for Rs 134 cr

Jubilant Ingrevia spurts after its Singaporean arm offloads 10% stake of Safe Foods Corp.

Jubilant Ingrevia arm divests 10% stake in Safe Foods Corp for $18.2 mn

Drug makers Granules India, Jubilant Cadista recall products in US market

Drug firms Granules India, Jubilant Cadista recall products in US market

Anurag Roy joins Astec Lifesciences board panel as CEO; Stock dives 4%

Anurag Roy joins Astec Lifesciences as CEO and Whole-time Director; Stock dives 4%

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock